Healing effect of ketanserin on chronic leg ulcers in patients with diabetes

Journal of the European Academy of Dermatology and Venereology : JEADV
P QuatresoozG E Piérard

Abstract

The treatment of chronic leg ulcers remains a stubborn problem in many patients. Topical 2% ketanserin ointment, a 5HT2-serotoninergic blocking agent, has been reported to improve healing of decubitus, venous, diabetic and ischaemic ulcers. The present double-blind intra-individual comparative study was performed in 12 women with diabetes presenting with at least two similar leg ulcers. In each subject, the two lesions were randomly assigned to be treated for 8 weeks by 2% ketanserin ointment or its unmedicated vehicle. assessments of the dynamics of wound healing were performed using computerized morphometry. Evaluations were performed at 2-week intervals for 8 weeks. A significant decrease in relative wound area was observed on the ketanserin-treated ulcers compared with the placebo group. Topical ketanserin is a valuable therapy for difficult-to-treat leg ulcers.

References

Jul 1, 1989·Journal of the American Academy of Dermatology·P A JanssenC M Lapière
Mar 1, 1993·Journal of the American Academy of Dermatology·D J MargolisG S Lazarus
Jan 1, 1997·Dermatology : International Journal for Clinical and Investigative Dermatology·C Piérard-FranchimontG E Piérard
Sep 2, 1999·The New England Journal of Medicine·A J Singer, R A Clark
May 16, 2002·Dermatology : International Journal for Clinical and Investigative Dermatology·I FumalG E Piérard

❮ Previous
Next ❯

Citations

Nov 1, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ritu GoyalJoachim Kohn
Jan 1, 2017·Journal of Diabetes Research·Luz E Gasca-LozanoJuan Armendariz-Borunda
Jan 25, 2020·The Cochrane Database of Systematic Reviews·Cathryn BroderickRachel Forster
Jun 30, 2015·The Cochrane Database of Systematic Reviews·Rachel Forster, Fania Pagnamenta
Oct 22, 2009·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Ahmad OryanAllen E Goodship
Aug 22, 2007·Journal of Wound Care·B Shivananda NayakA V Chalapathi Rao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

Journal of the American Academy of Dermatology
P A JanssenC M Lapière
Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
Henglin HaiYueping Xu
Dermatology Online Journal
Ashima Bhatia, Surya Prakash
© 2021 Meta ULC. All rights reserved